Comparative Impact of Surgical Treatment versus Pharmacological Therapy on Quality of Life in Patients with Chronic Secretory Otitis Media
DOI:
https://doi.org/10.71321/xzbwdw66Keywords:
secretory otitis media, quality of life, tympanostomy tube insertion, medication treatment, comparative studyAbstract
Objective: This study aimed to compare the impact of surgical treatment (tympanostomy tube insertion) and pharmacological therapy on quality of life (QoL) in patients with chronic secretory otitis media (SOM), focusing on symptom alleviation and functional recovery.
Methods: A prospective, longitudinal, non-randomized study was conducted at Chaohu Hospital, China, involving 80 SOM patients (aged 6–60 years) divided into surgical (n=38) and pharmacological (n=42) groups. QoL was assessed using a modified Chinese Chronic Ear Survey (CCES) before and 2–4 months post-treatment. The CCES evaluated activity restriction, symptom severity, and healthcare utilization. Statistical analysis via SPSS 28.0 included paired and unpaired t-tests.
Results: Both treatments significantly improved symptom scores (p<0.05), with surgery showing marginally greater efficacy (surgical group symptom score: 24.14→36.21 vs. pharmacotherapy: 26.47→35.15). However, neither intervention demonstrated statistically significant differences in overall QoL improvement (p>0.05). Activity limitation scores remained unchanged post-treatment (surgical: 13.21→13.28; pharmacotherapy: 13.62→14.91), indicating persistent functional challenges. No demographic factors (gender, education, socioeconomic status) influenced outcomes.
Conclusion: While both surgical and pharmacological treatments alleviate SOM symptoms, neither fully restores daily functioning, underscoring incomplete QoL recovery. These findings highlight the need for long-term evaluations and personalized treatment strategies. Future research should address study limitations, including small sample size and lack of laboratory-based assessments, to refine therapeutic approaches for holistic patient well-being.
References
[1] Rosenfeld RM, Shin JJ, Schwartz SR, Coggins R, Gagnon L, Hackell JM, et al. Clinical Practice Guideline: Otitis Media with Effusion Executive Summary (Update). Otolaryngol Head Neck Surg. 2016;154(2):201-214. https://doi.org/10.1177/0194599815624407.
[2] Lin W, Wang B, Wang M, Wang Y, Tuerdibieke Y, Qian C, et al. The Unneglectable Disease Burden of Otitis Media Among Children in China: A Systematic Review and Meta-analysis. Pediatr Infect Dis J. 2024;43(5):403-409. https://doi.org/10.1097/INF.0000000000004239.
[3] Clary RA, Bahadori RS, Muntz HR, Lusk RP. Bacteria in the middle ear and nasopharynx during tympanostomy tube insertion. Am J Otolaryngol. 1998 Sep-Oct;19(5):301-4. https://doi.org/10.1016/s0196-0709(98)90002-3.
[4] Chonmaitree T, Saeed K, Uchida T. A randomized, placebo-controlled trial of the effect of antihistamine or corticosteroid treatment in acute otitis media. J Pediatr. 2003;143(3):377-85. https://doi.org/10.1067/S0022-3476(03)00293-2.
[5] Yu X, Xu L, Xie Y, Huang M. Clinical study of the effect of mometasone furoate nasal spray treatment on hearing and in secretory otitis media in children. Clinics (Sao Paulo). 2024 Dec 12;80:100551. https://doi.org/10.1016/j.clinsp.2024.100551.
[6] Homøe P, Heidemann CH, Damoiseaux RA, Lailach S, Lieu JEC, Phillips JS, et al. Panel 5: Impact of otitis media on quality of life and development. Int J Pediatr Otorhinolaryngol. 2020 Mar;130 Suppl 1(Suppl 1):109837. https://doi.org/10.1016/j.ijporl.2019.109837.
[7] Nadol JB Jr, Staecker H, Gliklich RE. Outcomes assessment for chronic otitis media: the Chronic Ear Survey. Laryngoscope. 2000;110(3 Pt 3):32-35. https://doi.org/10.1097/00005537-200003002-00009.
[8] Li S, Ke J, Yang R, Zhang K, Pan T, Xin Y, et al. [Quality of life assessment after endoscopic and microscopic myringoplasty using Chinese version of the Zurich chronic middle ear inventory]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Apr;35(4):297-301. Chinese. https://doi.org/10.13201/j.issn.2096-7993.2021.04.003.
[9] Wu P, Cao X, Zhang R, Liu Y, Li H, Wang W, et al. The long-term efficacy and safety of balloon dilation eustachian tuboplasty combined with tympanostomy tube insertion for patients with otitis media with effusion: study protocol for a prospective randomized controlled trial. Trials. 2024 Aug 29;25(1):572. https://doi.org/10.1186/s13063-024-08405-1.
[10] Magnan J. Otite séro-muqueuse [Secretory otitis media]. Rev Prat. 1998;48(8):860-865.
[11] Doyle KJ, Kong YY, Strobel K, Dallaire P, Ray RM. Neonatal middle ear effusion predicts chronic otitis media with effusion. Otol Neurotol. 2004;25(3):318-322. https://doi.org/10.1097/00129492-200405000-00020.
[12] Bhusal P, Harrison J, Sharma M, Jones DS, Hill AG, Svirskis D. Controlled release drug delivery systems to improve post-operative pharmacotherapy. Drug Deliv Transl Res. 2016;6(5):441-451. https://doi.org/10.1007/s13346-016-0305-z.
[13] Planchard D, Besse B. Vers l'individualisation des prescriptions en oncologie Cancer bronchique non à petites cellules [Towards customized therapy for non small cell lung cancer]. Bull Cancer. 2008;95(10):951-958. https://doi.org/10.1684/bdc.2008.0719.
[14] Zhao Z, Bai B, Wang S, et al. Physical and psychological correlates of somatic symptom in patients with functional constipation: a cross-sectional study. BMC Psychiatry. 2024;24(1):134. https://doi.org/10.1186/s12888-024-05559-9.
[15] Fakhry H, Goldenberg M, Sayer G, et al. Health-related quality of life in childhood cancer. J Dev Behav Pediatr. 2013;34(6):419-440. https://doi.org/10.1097/DBP.0b013e31828c5fa6.
[16] Church J. Quality of life and patient-reported outcomes. Br J Surg. 2018;105(3):157-158. https://doi.org/10.1002/bjs.10824.
Type
Published
Data Availability Statement
Data supporting the findings of this study are available upon reasonable request from corresponding author Min Luo.
Issue
Section
License
Copyright (c) 2025 Cell Conflux
This work is licensed under a Creative Commons Attribution 4.0 International License.
